Assessment of Therapeutic Effect of Sunitinib by 11C-Acetate PET Compared with FDG PET Imaging in a Patient with Metastatic Renal Cell Carcinoma

Assessment of Therapeutic Effect of Sunitinib by 11C-Acetate PET Compared with FDG PET Imaging in a Patient with Metastatic Renal Cell Carcinoma

Although sunitinib shows a high response rate in patients with untreated metastatic renal cell carcinoma (mRCC), quite a few patients show no therapeutic effect. Therefore, it is crucial to distinguish the patients who respond to sunitinib from those who do not as early as possible after the adminis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nuclear medicine and molecular imaging 2011, 45(3), , pp.217-219
Hauptverfasser: Oyama, Nobuyuki, Takahara, Noriko, Hasegawa, Yoko, Tanase, Kazuya, Miwa, Yoshiji, Akino, Hironobu, Okazawa, Hidehiko, Kudo, Takashi, Fujibayashi, Yasuhisa, Yokoyama, Osamu
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Case Report
Imaging
Medicine
Medicine & Public Health
Nuclear Medicine
Oncology
Orthopedics
Radiology
방사선과학
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Although sunitinib shows a high response rate in patients with untreated metastatic renal cell carcinoma (mRCC), quite a few patients show no therapeutic effect. Therefore, it is crucial to distinguish the patients who respond to sunitinib from those who do not as early as possible after the administration of the therapy. We herein report a case of mRCC in which 11 C-acetate (AC) positron emission tomography (PET) showed an early therapeutic effect of sunitinib treatment 4 weeks after its administration.
ISSN:1869-3474
1869-3482
DOI:10.1007/s13139-011-0084-x